Popular Skinny Pills Linked to Digestive Problems
An October 2023 study1 in JAMA revealed that glucagon-like peptide-1 (GLP-1) receptor agonists prescribed for diabetes and weight loss increase your risk for gastrointestinal disorders, including pancreatitis, gastroparesis and bowel obstruction. The demand for weight loss products is estimated to grow at a record compound annual growth rate (CAGR) of 9.7% from 2023 to 2032.2… Read More »